Abstract
Neurological complications in opioid abusing Human Immunodeficiency Virus-1 (HIV-1) patients suggest enhanced neurodegeneration as compared to non-drug abusing HIV-1 infected population. Neural precursor cells (NPCs), the multipotent cells of the mammalian brain, are susceptible to HIV-1 infection and as opiates also perturb their growth kinetics, detailed mechanistic studies for their co-morbid exposure are highly warranted. Using a well characterized in vitro model of human fetal brain-derived neural precursor cells, we investigated alterations in NPC properties at both acute and chronic durations. Chronic morphine and Tat treatment attenuated proliferation in NPCs, with cells stalled at G1-phase of the cell cycle. Furthermore HIV-Tat and morphine exposure increased activation of extracellular signal-regulated kinase-1/2 (ERK1/2), enhanced levels of p53 and p21, and decreased cyclin D1 and Akt levels in NPCs. Regulated by ERK1/2 and p53, p21 was found to be indispensible for Tat and morphine mediated cell cycle arrest. Our study elaborates on the cellular and molecular machinery in NPCs and provides significant mechanistic details into HIV-drug abuse co-morbidity that may have far reaching clinical consequences both in pediatric as well as adult neuroAIDS.
Similar content being viewed by others
Abbreviations
- HIV-1:
-
Human Immunodeficiency Virus-1
- NPC:
-
Neural precursor cell
- ERK1/2:
-
Extracellular signal-regulated kinase ½
- IFNγ:
-
Interferon-γ
- Stat:
-
Signal Transducer and Activator of Transcription
- Sox2:
-
SRY (sex determining region-Y)-box2
- HAND:
-
HIV-associated neurocognitive disorders
- BrdU:
-
Bromodeoxyuridine
- EGFR:
-
Epidermal growth factor receptor
- FITC:
-
Fluorescein isothiocyanate
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- EthD-1:
-
Ethidium homodimer-1
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- CDK:
-
Cyclin dependent kinase
- esiRNA:
-
Endoribonuclease-prepared short interfering RNA
- EGFP:
-
Enhanced green fluorescent protein
- MEK1/2:
-
Mitogen activated protein kinase kinase
References
Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 92(18):8493–8497
Aguirre A, Rubio ME, Gallo V (2010) Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature 467(7313):323–327
Arguello AA, Fischer SJ, Schonborn JR, Markus RW, Brekken RA, Eisch AJ (2009) Effect of chronic morphine on the dentate gyrus neurogenic microenvironment. Neuroscience 159(3):1003–1010
Bada HS, Das A, Bauer CR, Shankaran S, Lester B, Wright LL, Verter J, Smeriglio VL, Finnegan LP, Maza PL (2002) Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 100(5 Pt 1):916–924
Behnke M, Smith VC (2013) Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics 131(3):e1009–e1024
Belcheva MM, Tan Y, Heaton VM, Clark AL, Coscia CJ (2003) Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling. Mol Pharmacol 64(6):1391–1401
Bell JE, Arango JC, Anthony IC (2006) Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. J NeuroImmune Pharmacol 1(2):182–191
Bokhari SM, Yao H, Bethel-Brown C, Fuwang P, Williams R, Dhillon NK, Hegde R, Kumar A, Buch SJ (2009) Morphine enhances Tat-induced activation in murine microglia. J Neurovirol 15(3):219–228
Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, Atkinson JH, Clifford DB, Collier AC, Marra CM, Gelman B, McCutchan JA, Duarte NA, Simpson DM, McArthur J, Grant I (2011) Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (1999) 58(2):154–162
Chambard JC, Lefloch R, Pouyssegur J, Lenormand P (2007) ERK implication in cell cycle regulation. Biochim Biophys Acta 1773(8):1299–1310
Eisfeld C, Reichelt D, Evers S, Husstedt I (2013) CSF penetration by antiretroviral drugs. CNS Drugs 27(1):31–55
Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986) Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78(4):678–687
Foshay KM, Gallicano GI (2008) Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev 17(2):269–278
Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39(5):749–765
Hahn YK, Vo P, Fitting S, Block ML, Hauser KF, Knapp PE (2010) Beta-chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration. J Neurochem 114(1):97–109
Hahn YK, Podhaizer EM, Hauser KF, Knapp PE (2012) HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation. Glia 60(12):1871–1887
Hauser KF, El-Hage N, Stiene-Martin A, Maragos WF, Nath A, Persidsky Y, Volsky DJ, Knapp PE (2007) HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem 100(3):567–586
Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D (2009) ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Mol Cancer Res 7(4):592–600
Kahn L, Alonso G, Normand E, Manzoni OJ (2005) Repeated morphine treatment alters polysialylated neural cell adhesion molecule, glutamate decarboxylase-67 expression and cell proliferation in the adult rat hippocampus. Eur J Neurosci 21(2):493–500
Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R (2005) Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 111(2):194–213
Krathwohl MD, Kaiser JL (2004) HIV-1 promotes quiescence in human neural progenitor cells. J Infect Dis 190(2):216–226
LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Gene Dev 11(7):847–862
Lawrence DM, Durham LC, Schwartz L, Seth P, Maric D, Major EO (2004) Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 78(14):7319–7328
Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Lu J, Finnegan LP, Maza PL (2002) The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 110(6):1182–1192
Lester BM, Lagasse L, Seifer R, Tronick EZ, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Liu J, Finnegan LP, Maza PL (2003) The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month. J Pediatr 142(3):279–285
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Gene Dev 9(8):935–944
Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, Chawda R, Shanahan TC, Schwartz SA (2008) Tight junction regulation by morphine and HIV-1 tat modulates blood–brain barrier permeability. J Clin Immunol 28(5):528–541
Malik S, Khalique H, Buch S, Seth P (2011) A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases. PLoS ONE 6(3):e18116
Mandyam CD, Norris RD, Eisch AJ (2004) Chronic morphine induces premature mitosis of proliferating cells in the adult mouse subgranular zone. J Neurosci Res 76(6):783–794
Mellon RD, Bayer BM (1998) Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res 789(1):56–67
Mirza AM, Gysin S, Malek N, Nakayama K, Roberts JM, McMahon M (2004) Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 24(24):10868–10881
Mishra M, Taneja M, Malik S, Khalique H, Seth P (2010) Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS. J Neurovirol 16(5):355–367
Noel RJ Jr, Marrero-Otero Z, Kumar R, Chompre-Gonzalez GS, Verma AS, Kumar A (2006) Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. Virology 349(2):440–452
Okamoto S, Kang YJ, Brechtel CW, Siviglia E, Russo R, Clemente A, Harrop A, McKercher S, Kaul M, Lipton SA (2007) HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 1(2):230–236
Ornoy A, Segal J, Bar-Hamburger R, Greenbaum C (2001) Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 43(10):668–675
Peng H, Whitney N, Wu Y, Tian C, Dou H, Zhou Y, Zheng J (2008) HIV-1-infected and/or immune-activated macrophage-secreted TNF-alpha affects human fetal cortical neural progenitor cell proliferation and differentiation. Glia 56(8):903–916
Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R (2007) Long-term HIV-1 infection of neural progenitor populations. AIDS (London, England) 21(17):2271–2281
Scaltriti M, Baselga J (2006) The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12(18):5268–5272
Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311–322
Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W, Kinzel N, Lawrence DM, Hazra R, Major EO (2007) Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol 13(3):274–283
Shapshak P, Duncan R, Minagar A, Rodriguez de la Vega P, Stewart RV, Goodkin K (2004) Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 9:1073–1081
Sheng WS, Hu S, Herr G, Ni HT, Rock RB, Gekker G, Lokensgard JR, Peterson PK (2007) Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther 322(3):957–963
Shoae-Hassani A, Sharif S, Tabatabaei SA, Verdi J (2011) Could the endogenous opioid, morphine, prevent neural stem cell proliferation? Med Hypotheses 76(2):225–229
Takahashi-Yanaga F, Sasaguri T (2008) GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 20(4):581–589
Tripathi A, Khurshid N, Kumar P, Iyengar S (2008) Expression of delta- and mu-opioid receptors in the ventricular and subventricular zones of the developing human neocortex. Neurosci Res 61(3):257–270
Wen H, Lu Y, Yao H, Buch S (2011) Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability. PLoS ONE 6(6):e21707
Acknowledgments
Technical assistance from Mr. Durga Lal Meena and Mr. Naushad Alam during the study, Senior Research Fellowship to SM, Project Assistantship to RS and core funding to PS laboratory from NBRC, Manesar and Department of Biotechnology, New Delhi, are greatly acknowledged.
Conflict of Interest
The authors declare that no conflicts of interest exist.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 201Â kb)
Rights and permissions
About this article
Cite this article
Malik, S., Saha, R. & Seth, P. Involvement of Extracellular Signal-Regulated Kinase (ERK1/2)-p53-p21 Axis in Mediating Neural Stem/Progenitor Cell Cycle Arrest in Co-Morbid HIV-Drug Abuse Exposure. J Neuroimmune Pharmacol 9, 340–353 (2014). https://doi.org/10.1007/s11481-014-9523-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-014-9523-7